secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001562762-22-000444
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q3 net sales $254.1M (+10.6% YoY); lowers FY22 non-GAAP EPS guidance to $2.03
--------------------------------------------------------------------------------

- Q3 net sales $254.1M, up 10.6% as-reported and 12.6% constant currency; GAAP net income $47.4M, +0.5% YoY.
- GAAP diluted EPS $0.47, non-GAAP diluted EPS $0.50; non-GAAP adjusted EBITDA $82.8M (32.6% of sales).
- U.S. Spine sales +9.0%, International Spine +11.1% as-reported (+24.8% constant currency); Enabling Technologies +19.0% to $24.1M.
- FY 2022 net sales reaffirmed at $1.025B; non-GAAP diluted EPS guidance lowered to $2.03 from $2.10 due to currency and tax.
- Company remains debt-free; operating cash flow $32.9M and free cash flow $20.9M in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000444/0001562762-22-000444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000444/gmed-20221108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer